BetterLife Pharma Inc. (BETRF)
CIK 1464165 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 145.5M shares as of May 30, 2025 (20-F). Share count fell from 172.1M to 51.4M between Jan 31, 2020 and Jan 31, 2021, a pattern consistent with a reverse split (roughly 1-for-3); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Funded — but tight
~12 months of cash · watch
Full breakdown: cash runway tool · source filing →
Warrants
Warrants outstanding: 15.2M underlying shares, as reported Apr 30, 2019 (10-Q).
Reported exercise price: $0.42 (aggregate figure as tagged; individual tranches vary).
Rough fully diluted estimate: 160.7M = 145.5M O/S + 15.2M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 145.5M | May 30, 2025 |
| + Warrants (aggregate, as tagged) (if exercised) | 15.2M | Apr 30, 2019 |
| Fully diluted estimate | 160.7M | +10.5% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 0 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full BETRF workspace